Rafael Holdings (RFL) Research & Development (2018 - 2026)
Rafael Holdings (RFL) reported Research & Development of $4.85 million for fiscal Q3 2026 (quarter ended Apr 30, 2026), up 61.6% from $3 million a year earlier and up 7.2% from the prior quarter.
Rafael Holdings (RFL) Research & Development (2018 - 2026) Analysis & Trends
Over the twelve months ended Apr 30, 2026, Rafael Holdings' Research & Development came in at $17.1 million, up 150.7% year-over-year; for FY2025 (ended Jul 31, 2025), it came in at $12.82 million, up 207.5% from FY2024.
- Research & Development has a five-year compound annual growth rate of 39.9% (FY2020 to FY2025).
- By fiscal year, Research & Development came in at $4.17 million in FY2024 (-33.9%), $6.31 million in FY2023 (-27.8%), $8.74 million in FY2022 (+78.2%) and $4.91 million in FY2021 (+105.2%).
- Five-year quarterly Research & Development spans a low of $232,000 in fiscal Q4 2025 and a high of $7.48 million in fiscal Q1 2026.
- Year over year, Research & Development has now increased in each of the last three quarters, with growth averaging 145.5% over the last eight quarters.
- The high point for year-over-year Research & Development in five years was fiscal Q1 2026 (growth of 464.4%); the low point was fiscal Q4 2025 (a decline of 85.0%).
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at $4.53 million (Q2 2026), $7.48 million (Q1 2026) and $232,000 (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Rafael Holdings | 102.93 Mn | 108.34 Mn | 163,000.00 | 4.85 Mn |
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 4.85 Mn |
| Jan 31, 2026 | 4.53 Mn |
| Oct 31, 2025 | 7.48 Mn |
| Jul 31, 2025 | 232,000.00 |
| Apr 30, 2025 | 3.00 Mn |
| Jan 31, 2025 | 947,000.00 |
| Oct 31, 2024 | 1.33 Mn |
| Jul 31, 2024 | 1.54 Mn |
| Apr 30, 2024 | 1.53 Mn |
| Jan 31, 2024 | 612,000.00 |
| Oct 31, 2023 | 489,000.00 |
| Jul 31, 2023 | 1.27 Mn |
| Apr 30, 2023 | 740,000.00 |
| Jan 31, 2023 | 2.23 Mn |
| Oct 31, 2022 | 2.08 Mn |
| Jul 31, 2022 | 1.84 Mn |
| Apr 30, 2022 | 1.41 Mn |
| Jan 31, 2022 | 3.34 Mn |
| Oct 31, 2021 | 2.15 Mn |
| Jul 31, 2021 | 1.56 Mn |
Rafael Holdings Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=RFL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "RFL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=RFL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();